Approching and Studing Bacterial
Diseases
1) Microbes and Diseases
- Establishing a Connection: Koch’s Postulates
- Concepts of Disease
2) Measuring Infectivity and Virulence
- Animal Models
- Competition Assays
- Tissue Culture and Organ Culture Models
- Good Information about the Pathology of a Disease
The discovery that the bacterium Helicobacter pylori
causes most of the ulcers brought to the fore an old
problem in infectious disease research:
How does one prove that a particular microorganism
causes a disease?
How would you test this hypothesis?
How to avoid a possible bias?
Approching and Studing Bacterial Diseases
Microbes and Diseases: Establishing a Connection:
Koch’s Postulates
How to convince proponents of competing views?
1. The microbe must be associated
with the lesions of the disease.
This is, the microbe should be
found in diseased tissue but not in
healthy tissue.
2. The microbe must be isolated from
the lesions of the disease as a
pure culture.
3. A pure culture of the microbe
should cause the symptoms of the
disease if it is inoculated into
humans or into animals.
4. The microbe must be re-isolated in
pure culture from the humans or
animals used to satisfy the third
postulate
Koch’s Postulates
The first Koch’s postulate and relation between
Chlamydia pneumoniae and atherosclerosis
Chlamydia pneumoniae is frequently isolated from
atherosclerotic plaques but only occasionally isolated
from healthy blood vessel tissue.
The fact that C. pneumoniae is occasionally isolated
from healthy blood vessel tissue blurs the clear line
implicit in Koch’s first postulate.
Although C. pneumoniae is isolated from atherosclerotic
plaque samples, it is not isolated from all such samples.
It means, C. pneumoniae is associated with lesions of
the disease most of the time but not all of the time.
The first Koch’s postulate and Helicobacter
pylori as etiologic agent of ulcers
Over half the people in developed countries and nearly
all of the people in developing countries carry H. pylori
in their stomachs, but only a small number of these
people develop ulcers.
The same pattern is seen in a number of bacterial
diseases; the bacterium colonizes many people, but
only those with some predisposing condition develop a
symptomatic infection.
The Second Postulate: Isolating
the bacterium in pure culture
Some bacteria are more difficult to cultivate
than others
- C. pneumoniae only grows inside human cells
- H. pylori requires a special atmosphere to
grow on agar medium
- Treponema pallidium has never been isolated
as a pure culture.
What is a modern alternative to cultivate
disease-causing bacteria?
The Third Postulate: Showing that the
isolated bacterium causes disease in
humans or animals
The postulate that is the most difficult to satisfy
WHY?
H. pylori and C. pneumoniae
Barry Marshall (J.R. Warren)
Rabbit model of atherosclerosis: a special breed of rabbit that is prone to
develop atherosclerosis is fed a high-fat diet to show that infection with C.
pneumoniae increases the development of atherosclerotic plaque
How closely should an animal model mimic the disease in humans?
The Fourth Postulate: Reisolating the
bacterium from the intentionally infected animal
This postulate is fairly easy satisfy and very important to
prove the causative relation between a bacterium and a
disease
WHY IS SO IMPORTANT?
Consider the rabbit model of C. pneumoniae infection
and cardiovascular disease
A Fifth Koch Postulate?
C. pneumoniae – satisfied all four of Koch’s
postulates if one accepts the rabbit model as a good
model for disease. Still there are many skeptics.
H. pylori, even the use of human volunteer did not
convince everyone
THE FIFTH POSTULATE: The information about
the microbes should enable scientists to design
effective therapeutic or preventive measures for
eliminating the disease.
HIV / AIDS and syphilis
Microbiota Shift Disease Problem
- Periodontal disease
- Bacterial vaginosis (associated with higher
risk for preterm birth)
- Inflammatory bowl disease
Concepts of Disease
1. Variety of Human-Microbe Interactions
- Differences in susceptibility from person to person
-Variations among different strains of the same bacterial species
Lost of virulence
Differences between isolates
The outcome of microbe-human encounter depends on the
infected person’s defenses against disease and on the traits
of the infecting strain
1) Disease-causing bacteria evolved specifically to cause human
disease.
2) Disease-causing bacteria are actually trying to achieve an
equilibrium with humans that does not result in disease, and that
disease symptoms result when this equilibrium is not achieved.
3) Humans are more often than not accidental hosts of bacteria that
may be able to cause human disease but have actually evolved to
occupy some other niche.
In this view, bacteria entering the humen body react by activating
stress responses, producing disease symptoms in the process
2. Views of the Microbe-Human Interaction
Ad.1. A bacterium that causes disease only in human and has no external reservoir
Ad.2. A bacterium that causes an asymptomatic carrier state in most of humans it infects
Ad.3. A bacterium that spends most of its time outside human body and only occasionally
causes human disease
3. Terminology
1) The term “host-parasite” is widely used to describe the human-
microbe interaction
2) Colonization of the body by bacteria capable of causing disease
is called infection
3) An infection producing symptoms is called disease
4) The word colonization means that a bacterium occupies and
multiplies in a particular area of the human body. Colonization is
not synonymous with disease, nor it is necessarily synonymous
with infection.
5) The terms colonization, infection, and disease may vary in their
applicability depending on the status of the person colonized.
6) People, who are infected but do not have detectable symptoms
are called asymptomatic carriers (example of Typhoid Mary)
3. Terminology, cont.
7) Symptoms of bacterial infection are defined as effects of
bacterial infection that are apparent to infected person (Example:
Chlamydia trachomatis / cervix infection / no pain and vaginal
discharge / inflammation / fallopian tubes shut / infertility)
8) Virulence (or pathogenicity) is defined as the ability of a
bacterium to cause infection
9) Virulence factor (or mechanism of pathogenesis or virulence
mechanism) denotes a bacterial product or strategy that
contributes to virulence or pathogenicity
Problems:
– Two or more factors
– A virulence factor in one type of bacteria is
not a virulence factor in another type
– Is a housekeeping protein a virulence factor?
– The loss of trait makes a bacterium more
virulant
An experimental definition of virulence factor: A
loss of the factor by the bacterium results in a
decrease in its ability to cause disease
4. Opportunists
Bacteria that normally do not cause disease in healthy people but
can cause disease in people whose defenses have been impaired
Example: Pseudomonas aeruginosa and burns or cystic fibrosis
Opportunists vs. primary pathogens, definition problems
Example: Streptococcus pneumoniae
Measuring Infectivity and Virulence
Animal Models
Human Volunteers
- ethical considerations
Zidovudine (AZT) therapy test in Thailand in 1990s
The Tuskegee experiment
(from the early 1930s to 1972)
“Involunteer studies” – in which infectious
disease outbreaks are studied in retrospect to
obtain information about disease transmission in
humans (Example of a school bus driver)
Nonhuman Animal Models
- Laboratory rodents
Rats do not have a gallbladder
Coprophagy
Different courses of some human diseases in rodents
Example: Salmonella enterica serovar Typhimurium: diarrhea
in humans, systemic disease in mice.
S. typhi cause typhoid fever in humans, does not infect mice
Ferrets as a model for ulcers
Caenorhabditis elegans
A Perfect Animal Model
• Symptoms and distribution
• A route of infection
• The ease with which the animal model can
be manipulated genetically
– knockin and knockout mice
• Lewis b antigen Le
b
mouse
• The sickle-cell trait conferes immunity to malaria
• A defective chemokine receptor confers resistance
to HIV
ID
50
and LD
50
50
100
10
0
10
2
10
4
Competition Assays
Tissue Cultures and Organ Culture Models